Osentia Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $580K
Latest Deal Amount
  • Investors
  • 5

Osentia General Information

Description

Developer of an osteoporosis screening test designed to help patients take early steps to manage osteoporosis. The company's test identifies the risk of fragility fracture by analyzing finger or toenail clippings, enabling users to remain aware and take care of their bone health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Medical Supplies
Primary Office
  • 64 New Cavendish Street
  • London W1G 8TG
  • England, United Kingdom
+44 0344 000 0000

Osentia Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Osentia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 08-Jan-2021 $580K 00.000 00.000 Completed Generating Revenue
8. Later Stage VC 02-Apr-2019 00000 00.000 00.00 Completed Generating Revenue
7. Later Stage VC 04-Jun-2018 00000 00.00 00.000 Completed Generating Revenue
6. Later Stage VC 14-Nov-2016 00000 00.00 00.000 Completed Generating Revenue
5. Later Stage VC 31-May-2015 00.000 00.000 00.000 Completed Generating Revenue
4. Later Stage VC 01-Feb-2014 00000 00.000 Completed Generating Revenue
3. Later Stage VC 01-Sep-2012 000.00 00.000 Completed Generating Revenue
2. Later Stage VC (Series A) 22-Jun-2011 $2.16M $3.18M Completed Startup
1. Early Stage VC 13-Jun-2006 $1.03M $1.03M Completed Startup
To view Osentia’s complete valuation and funding history, request access »

Osentia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 000.00 000.00 000.00 00.000
Ordinary 000,000 00.000000 000.00 000.00 000.00 00.000
Ordinary 4,190 $0.134640 $9.64 $9.64 $9.64 1.26%
To view Osentia’s complete cap table history, request access »

Osentia Executive Team (8)

Name Title Board Seat Contact Info
Alan Ransome Chief Executive Officer
You’re viewing 1 of 8 executive team members. Get the full list »

Osentia Board Members (4)

Name Representing Role Since
Barry Clare Osentia Chairman 000 0000
Richard Guest Self Board Member 000 0000
You’re viewing 2 of 4 board members. Get the full list »

Osentia Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Enterprise Equity Venture Capital Venture Capital Minority 000 0000 000000 0
Kernel Management Partners Venture Capital Minority 000 0000 000000 0
Newable Corporation Minority 000 0000 000000 0
Richard Guest Angel (individual) Minority 000 0000 000000 0
Seroba Life Sciences Venture Capital Minority 000 0000 000000 0
To view Osentia’s complete investors history, request access »